使用ENROUTE神经保护系统在高危颈动脉血运重建中以经颈动脉血运重建为中心方案的相关结局
本回顾性研究描述了在高危颈动脉血运重建患者中,使用ENROUTE神经保护系统(ENPS)进行经颈动脉血运重建(TCAR)的围术期和早期随访结果,排除了ROADSTER-2注册研究患者。2015年12月至2018年1月共治疗75条颈动脉,技术成功率97.3%,围术期同侧卒中率2.7%,心肌梗死发生率0%,死亡率2.7%,平均随访8.0±6.7个月无支架再干预。作者认为动态逆流TCAR使用ENPS在ROADSTER-2法规之外仍安全、可行、有效。
要点
- 75条颈动脉接受TCAR/ENPS,技术成功率97.3%(73/75)。
- 围术期同侧卒中率2.7%(n=2),心肌梗死0%,死亡率2.7%(n=2),无颅神经损伤。
- 平均随访8.0±6.7个月,无支架再干预,1例轻度支架内狭窄和1例无症状支架血栓。
核心结论
- 作者报告,在ROADSTER-2法规之外,使用ENPS进行动态逆流TCAR仍安全、可行、有效,术后卒中、心肌梗死和死亡风险极低。
研究设计与样本
- 回顾性综述,纳入本机构所有因传统颈动脉内膜切除术后并发症高风险而接受TCAR/ENPS的患者,排除所有ROADSTER-2注册研究患者,仅分析在试验法规之外治疗的患者。
- 2015年12月至2018年1月共治疗75条颈动脉。
主要发现
- 所有干预的颈动脉中,有症状且狭窄≥50%者占46.7%,无症状且狭窄≥80%者占53.3%(经双功超声和CT血管造影评估)。
- 技术成功率为97.3%(73/75),治疗失败归因于1例颈总动脉夹层和另1例颈外动脉支架释放不当。
- 围术期(30天)同侧卒中率为2.7%(n=2),心肌梗死发生率为0%,死亡率为2.7%(n=2),未观察到颅神经损伤。
- 平均随访8.0±6.7个月,无颈动脉支架需要再干预,但观察到1例轻度(<50%)支架内狭窄和1例无症状支架血栓。
- 随访期间观察到另外1例同侧卒中,可能源于心脏。
临床怎么用
- 作者报告,使用ENPS进行动态逆流TCAR在ROADSTER-2法规之外仍安全、可行、有效,术后卒中、心肌梗死和死亡风险极低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This investigation describes the perioperative and early follow-up results associated with transcarotid artery revascularization (TCAR) in patients not participating in the Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure II (ROADSTER-2) registry using the ENROUTE neuroprotection system (ENPS; Silk Road Medical, Sunnyvale, Calif). METHODS: A retrospective review was performed capturing all TCAR/ENPS procedures in patients deemed to be at high risk for complications after traditional carotid endarterectomy. All patients enrolled in the ROADSTER-2 registry were excluded, leaving only those treated outside trial regulations for analysis. Preoperative demographics, intraoperative variables, and perioperative and follow-up outcomes were abstracted and reported herein. RESULTS: From December 2015 to January 2018, there were 75 carotid arteries treated at our institution. All interventions were performed on carotid arteries that were symptomatic with ≥50% stenosis (46.7%) or asymptomatic with ≥80% stenosis (53.3%) by duplex ultrasound and computed tomography angiography. Technical success in our series was 97.3% (73/75), with treatment failures attributed to one case of common carotid artery dissection and another secondary to stent maldeployment in the external carotid artery. Perioperative (30-day) ipsilateral stroke rate was 2.7% (n = 2), myocardial infarction incidence was 0%, and mortality rate was 2.7% (n = 2). We did not observe any cranial nerve injuries. After a mean follow-up of 8.0 ± 6.7 months, no carotid stents required reintervention. However, we noted one instance of minor (<50%) in-stent stenosis and one asymptomatic stent thrombosis. One additional ipsilateral stroke was observed on follow-up, probably from a cardiac source. CONCLUSIONS: We report that dynamic reverse-flow TCAR using the ENPS continues to be safe, feasible, and efficacious with minimal risks of postoperative stroke, myocardial infarction, and mortality outside of ROADSTER-2 regulations.
引用
- Wang SK, Fajardo A, Sawchuk AP, et al. Outcomes associated with a transcarotid artery revascularization-centered protocol in high-risk carotid revascularizations using the ENROUTE neuroprotection system. J Vasc Surg. 2018. PMID: 30301690. doi:10.1016/j.jvs.2018.06.222
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。